Diario Judío México - An Israeli band that transmits electrical signals and stops migraine pain has been approved by the European Commission for pharmaceuticals.

Relivion, patented by Netanya-based Neurolief, is a brain neuromodulation device geared toward helping individuals who suffer from a range of  neurological and neuropsychiatric disorders, including migraine headaches.

The band is connected to a cellular application directed by the patient. It works by transmitting electric currents to the brain. The signals stimulate six major nerve branches around the head, which conduct the stimulation directly to the brainstem. This creates “neuromodulation,” which blocks the nerve signals that cause the pain. Over time, the system “learns” the optimal treatment for each specific patient.

It is the first device of its kind considered safe for outpatient use.

Migraines can cause moderate to severe pain, including throbbing or pulsing. Often, the pain occurs only on one side of the head. Side effects can be nausea, weakness or sensitivity to light and sound.

According to the Migraine Research Foundation, migraines are  the third most prevalent illness in the world. Nearly one in four United States households have someone who suffers from these headaches. The foundation said around 12% of the American population – including children – suffers from migraines. They are more common in women than men.

In , the prevalence of migraines among those aged 21 and over is 5.4%, affecting 3.2% of men and 7.5% of women, according to Hadassah Medical Center.


Deja tu Comentario

A fin de garantizar un intercambio de opiniones respetuoso e interesante, DiarioJudio.com se reserva el derecho a eliminar todos aquellos comentarios que puedan ser considerados difamatorios, vejatorios, insultantes, injuriantes o contrarios a las leyes a estas condiciones. Los comentarios no reflejan la opinión de DiarioJudio.com, sino la de los internautas, y son ellos los únicos responsables de las opiniones vertidas. No se admitirán comentarios con contenido racista, sexista, homófobo, discriminatorio por identidad de género o que insulten a las personas por su nacionalidad, sexo, religión, edad o cualquier tipo de discapacidad física o mental.